Biomarkers and potential therapeutic targets driving progression of non-alcoholic steatohepatitis to hepatocellular carcinoma predicted through transcriptomic analysis
Hui Fan, Rong Wang, Bin Wen, Jing Xiong · 2024
Read Biomarkers and potential therapeutic targets driving progression of non-alcoholic steatohepatitis to hepatocellular carcinoma predicted through transcriptomic analysis by Hui Fan, Rong Wang, Bin Wen, Jing Xiong (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11652351.txt.
Description
Hui Fan, Rong Wang, Bin Wen, and Jing Xiong mine gene activity data for markers of the slide from fatty liver disease to liver cancer. Their study appeared in 2024. The liver condition, called NASH, is now the world's most common chronic liver disease and can end in cancer. The team merged six public microarray data sets and ranked genes by consistent change. They found 62 genes turned up and 24 turned down across studies.
Those genes grouped patients into molecular subtypes tied to tumor stage and survival in a large cancer atlas. Single-cell data then showed which liver cell types carry the signals. The authors propose the gene set as candidate markers and drug targets. They stress that lab and clinical tests must confirm any of them.
Catalog record
| CREATOR | Hui Fan, Rong Wang, Bin Wen, Jing Xiong |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |